SINDROM KAWASAKI
ABSTRAK
!
"
#$
#
%&
#
'()
#
!
# $
&(((
"
$
terdiagnosis kurang dari 100 per tahun dan misdiagnosis sering terjadi. Oleh karena itu, penting
#
"
"
#
!
*#
klinis mayor sindrom Kawasaki terdiri atas demam, vaskulitis multisistem akut, eksantema
+"
-
#
#
#"
/
- "
tangan dan telapak kaki atau deskuamasi periungual, serta limfadenopati servikal nonsupuratif
2
34"&
56
!
$##
$
7
&84&)
#
#
9 $
$
#
#
#
jangka panjang terhadap gejala sisa koroner. Tatalaksana sindrom Kawasaki adalah Intra Venous
2:*6
"
-
#
:*
!
5
#"
5
#
#
:*
#
4(
!
penyakit.
ABSTRACT
!;
$
5
$
5
"
5$
--5
-
5
&
$8"
!
'()
-
;
5 5
-
-
55
5 5
-
!;
$
5
#
&(((
5"
#
cases diagnosed were less than 100/year and misdiagnosis are common. It is important to know
"
$"
5 5
-
-
!;
$
5 5
-
-
!;
$
-"
5
$
5
"
$5
= "
#
#
#
=
5
"
/ "
$
>
"
5
5
$ $
2
?4&
56
!;
$
5
5
5>
5
5 $
5
55
&84&)
5
#
5
$
-
5 $
8
-
5 $
>
@
-
!;
$
5
-
#
2
:*6
"
#
$
--5
-
5#
-
:*
>
good, except when there is coronary arterial aneurism and if IVIG therapy is initiated more than
10 days from onset of the disease.
Korespondensi: Keywords:
!"
#$
%
$
&'
72
@
C
D
E $ Sindrom Kawasaki
0
&
!#$
" eritema pada telapak
9
-
+
H
M
H*M@0
,
&
&
.
&
+
34 ETIOLOGI DAN PATOGENESIS
,1-4 %
* 0
9
0
9
*
-!;
atau
-
*
.
mucocutaneous lymph node syndrome
*
-
*
-
0
;
&
-
4<-
0
&
&
* 0
0
-
=<;=>1-4 sel @8 O@P
!
&
*
.
.
9
-
?
;?
*
+Q,;4
-
0
tumor necrosis factor +N",;RQ;E
-
vascular endothelial growth factor
*
-
9
+#
); 4AA<,
Q;=+Q;
@
*
=H,
*Q;=H
0
*
A<>
&
0
0
.
-
*
-
B-
&
*
-
-
**
-
0
;.
;
@
.
Q;4N";R
&+N",;T4EA
-
*1,4,6,7 Q
* 0
&
.
%
;9
EPIDEMIOLOGI $5
"
5
B, dan human
*
- adenovirus
?
*
-
E;4=
*
4)
*
4( ; =<F 4<<<<<
/
- Staphylococcus aureus pada 11 pasien dan streptokokus
G
?
1H
=
4EA4<
;
$
-4$4<
-
*
444
4<<<<<
/
-*0
GEJALA KLINIS
0
0
*
-
1
Gejala umum
-
E<
-
0
*
0
&
$
;
?
&
.
"
0
(;4-
-
- =<<<
EA
4<);4<U"
4<<<<<
/
-%
*
4;=
-
-
);
4AEE
=<<=
4E4<<<<<
1,2,6-8
0
.
-
&
Insidens SK per tahun di Indonesia diperkirakan
"
-
;=
<<<
0
-
-@
0
4<<
- *
&
"
.
=(
*
-
()
: :
JL
M
N
@
N(4QR
UN
8
UU
-
(<-
&
H
*
W
1,2,11
-
0
-
Manifestasi nonmukokutan
-
%
F<;A<>
-
Q
&
0
0
.
0
&
-
&
.
%
.
W
.
0
-
&
.
-
;(1,6,11
.
?
0
0
&
-
1,11 Deskuamasi periungual
9
0
@
0
;0
*
-
&
4-
)
&
-
Q
;=
;)-
@
-
-
E>
X
&
+
&
@
&
,
)<>
&
0
-
*2,4,6
1,6
0
-
.
<>
Q
&
Edema dan eritema tangan dan kaki
0
0
%
0
-
-
-
%
-
&X
*
-
-
%
-&
&0
.
&+
>
*,
+.
&
,.
&
-
&
=)E44
-
-
Gejala mukokutan
&
6,11
Erupsi polimorfik, dermatitis skarlatiniformis pada
0
F<;A<>
-
-
0
0
.
Kelainan mukosa orofaring
&
.
0
&
*
;
*
-
1
&
&
-
-
&
.
95
H8*
W
&
!#$
&
4,6 tongue
-
0
F<;A<>
6,11
Erupsi kulit
Kelainan kuku
eritematosa polimorfik, erupsi difus makular,
skarlatiniformis, $
-8 +
, *
-
(>
&
?
-
%
@
0
.
-
F
0
-
-
Q
-
-
.
%
-
-
-
-
1,6
74
@
C
D
E $ Sindrom Kawasaki
9
;
-+/)!Q,
-
&
0
?
0
.
0
&
.
*
-
*
4
=
-
0
menunjukkan temuan spesifik, terdapat edema papila
-
-
B
-
&
-
.
-
-
-
-
-
4)
-
-
-
1+%X,0
-
-
-
-
*
&
X
--
0
%X
.
H
0
@&
-
1.
\
0
.
.
-
*;
1
0
0
0
%
&
=;
-
4,6,12 &
.
&
American Heart Association
Kelainan kutan yang jarang +?G?,
&
*
;
?
=
*X
&
= ;E
;F
*
4=
Pemeriksaan Magnetic Resonance Imaging (MRI) dan
ZX
-
[X +
4AA),
* ?
&
-
*
)(
-
&
1,14,15 Kelainan koroner
FE>
+E
(
,
*
-@
F>
W
&
*
+
)
dan cardiac ultrasound scanning15
0
&
.
&
DIAGNOSIS
4;=E444)
@
*
?G?
0
4@
*
PEMERIKSAAN LABORATORIUM
0
-
&
*
1
1
?
-
Tabel 1. Kriteria diagnostik sindrom Kawasaki
&
@
-
-
0
-
-
*
$
-
1 0
0
.
&
<<<<< -
4<<<<<<!)
&
2 *
-
&
$
0
1
-
=;)
0
&
) *
-
$
&&
1,4
-
4 %
1
(>
H
&
5 Q
&
.
&
+
34,
H85
R4;
-
SK incomplete
E;4<
Q
0
0
-
-
&
*
--
*
0
-
*
incomplete
*
.
3-
75
: :
JL
M
N
@
N(4QR
UN
8
UU
*0
8
5
$ $
$
1,14
=
-
ZX
*4=4A
DIAGNOSIS BANDING
*
@
*
- scarlet fever,
-.
Staphylococcal Scalded Skin Syndrome (SSSS), infeksi
.
+
&
.
,%
M
&
+%M,
*.;- +**, !#$
0
&
tongue
&.
&
*
-
;
0
!#$
0
*
0
*+
<>
,
-
**
%M
**
&
.
%M
-
& X
**** 0
ZX
-
&
.
ZX
-
-
0
.
ZX
-
-
4)44 *
4)F4E4F
PENATALAKSANAAN KOMPLIKASI
G
*
.
-
-
-
-
-
@
*
&0
0
4<-
-
0
-
-
4
*
%
0
&Q
0
0
G
;4>
0 0
-
*
-
*
0
1,6
;
9
-
0
0
-
Penatalaksanaan topikal 7,20
-
&
Q
.
*
*
&
1,6
&
@
0
0
&
1
Penatalaksanaan sistemik
difus atau parut fokal pada daerah iskemia miokardial atau
*#
&
9
&G+?=<4),
-
+ZX,
-
W
&
* =<<-
@
0
=<4=-
A
?
*4(
ZX
= !
&
@
0
=)
=4
4<;4= 0
4< -
0
4
*
4<>
4
&
ZX
Xg;M
% +M
=<44,
ZX
4!
*
;
&
.
20
ZX
-
&
-
-
12,16-18
?
PROGNOSIS
&
W
@
?
F<;4<<
*
ZX
4
!-
4-
-
- 0
-
);!
E;F
+=<<F,
-
76
@
C
D
E $ Sindrom Kawasaki
4<-
-
DAFTAR PUSTAKA
ZX
4 Q @qM M
GO Q?[ Kawasaki syndrome. Dalam:
- " M%
?x[&&??"X
-Q?
g*
$
5 %
;(Nq$
0
W
-
MX
;G
y=<<F-4E=E;))
0
= * M9" N [ Kawasaki disease @
$
HM
.
-
*
9M@ X * *- N 9-
H%
Nelson
=#
-
5
`
84'-
-
$*
y=<44-FE=;(
0
) [Q
9 O !
@
$ .
-
?@ GGq
?O
\;
=#
-
5
*
5
#$
$
$ 5
=<4)y4E)$4=E;)4
-
GH\BQ
22 F *
H
O
N?=<4=yA$=z
%** +=<4),
-
A q
MQ@qM*-
.MEvidence for the involvement
-
#5
"
5
"
!
-
-
syndrome"%M*M
Q=<<<y4A=$4;(
.
*
4<9
*M
."-?G
MB*
-OX
%G
-
.
#
8N
5
5
!
!
$
-
*
$
#
!
`
$6b
@
*
?G? $ $
$ b
5
!
$5
@
*
$
2`6
$
5
#$
-
!
.
0
disease.??
@
=<<AyE<$4E;A
*
=<Xg;M
%O
|?ZO
-?*O;%-
Z!
55
#$
5
5
0
5
H
!
\$
-
!
=<4=y
4E4$)4;A4
0
ZX
-
4<-
0
2)
%**X
@X
.
9
?Q.*BN
*H
Vascular health in Kawasaki disease?OO
=<4)yE=$444;=4
77